Carborane-Appended Levodopa For Prostate-Specific Membrane Antigen and Boron Neutron Capture Therapy
Publication Date
2021
Document Type
Dissertation/Thesis
First Advisor
Hosmane, Narayan S.
Degree Name
M.S. (Master of Science)
Legacy Department
Department of Chemistry and Biochemistry
Abstract
A multi-step organic synthetic method to attach carborane cages to biocompatible organic compounds for application in Boron Neutron Capture Therapy (BNCT) was conducted. Boron Neutron Capture Therapy is a form of radiation therapy that promises a new and effective form of cancer treatment that involves the destruction of tumor cells using an isotope of boron (10B). The effectiveness of this therapy depends on the boron content accumulated in cancerous tissue. Carboranes are boron-rich clusters that possess unique physical and chemical properties making them suitable for a wide range of applications including medicinal chemistry. Because of their high boron content, carborane-appended molecules have been synthesized for BNCT application. Levodopa (L-DOPA) is a large neutral amino acid derived from tyrosine and a precursor for catecholamines such as dopamine, norepinephrine, and epinephrine. This amino acid possesses the ability to cross the blood-brain barrier and great biocompatibility. L-DOPA also contains the necessary functional groups found in prostate membrane receptors. Prostate-Specific Membrane Antigen (PSMA) is a membrane expressed in prostate tissue, including carcinoma, and can, therefore, be targeted by using L-DOPA containing PSMA receptor site ligands, followed by the addition of carborane cages. These characteristics of L-DOPA make it a promising carrier molecule for BNCT studies, including the possible treatment of prostate cancer.For this project, an organic synthetic method has been conducted to couple carborane cages to L-DOPA carrier molecules via substitution and click reactions. 1-methyl-o-carborane was used as the boron source compound and attach to L-DOPA to synthesize carborane-appended L-DOPA, as well as carborane-appended L-DOPA conjugated PSMA for BNCT application in the possible brain and prostate cancer treatments, respectively.
Recommended Citation
Macias, Alejandra, "Carborane-Appended Levodopa For Prostate-Specific Membrane Antigen and Boron Neutron Capture Therapy" (2021). Graduate Research Theses & Dissertations. 7388.
https://huskiecommons.lib.niu.edu/allgraduate-thesesdissertations/7388
Extent
62 pages
Language
eng
Publisher
Northern Illinois University
Rights Statement
In Copyright
Rights Statement 2
NIU theses are protected by copyright. They may be viewed from Huskie Commons for any purpose, but reproduction or distribution in any format is prohibited without the written permission of the authors.
Media Type
Text